These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25406143)

  • 21. Drug-Induced Sweet Syndrome.
    Shaikh MB; Krunic AL
    J Allergy Clin Immunol Pract; 2019; 7(7):2400-2401. PubMed ID: 31401061
    [No Abstract]   [Full Text] [Related]  

  • 22. Renin-Angiotensin system blockers and cardiovascular death in kidney recipients.
    Opelz G; Döhler B
    Transplantation; 2014 May; 97(10):e62-3. PubMed ID: 24827898
    [No Abstract]   [Full Text] [Related]  

  • 23. A cognitive conundrum. What is causing changes in cognition for this older adult?
    Karch AM
    Am J Nurs; 2005 Oct; 105(10):33, 35. PubMed ID: 16205404
    [No Abstract]   [Full Text] [Related]  

  • 24. Renin-Angiotensin system antagonists and mortality in patients with heart failure.
    Fonarow GC; Ahmed A
    JAMA; 2013 Mar; 309(11):1107. PubMed ID: 23512045
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan NM
    J Am Soc Hypertens; 2015 Aug; 9(8):582-3. PubMed ID: 26319536
    [No Abstract]   [Full Text] [Related]  

  • 26. Renin-Angiotensin system antagonists and mortality in patients with heart failure--reply.
    Lund LH; Benson L
    JAMA; 2013 Mar; 309(11):1107-8. PubMed ID: 23512046
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cotrimoxazole-induced leukocytoclastic vasculitis].
    Martín Guerra JM; Martín Asenjo M; Novoa Fernandez C; Prieto de Paula JM
    Rev Esp Geriatr Gerontol; 2020; 55(3):181-182. PubMed ID: 31882161
    [No Abstract]   [Full Text] [Related]  

  • 28. Troponin leak-Janus face of polypharmacy.
    Senthilkumaran S; Jena NN; Ananth C; Thirumalaikolundusubramanian P
    Am J Emerg Med; 2014 Sep; 32(9):1129. PubMed ID: 24961150
    [No Abstract]   [Full Text] [Related]  

  • 29. [Instability due to trimethoprim-sulphamethoxazole in an immunocompetent nephrectomy patient, with UTI due to HBP].
    Oyarzabal I; Zubiaurre L; Barandiaran A; Gutiérrez G
    Aten Primaria; 2005; 36(3):170-1. PubMed ID: 16029750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Be careful when combining ACE inhibitors and angiotensin receptor blockers].
    Markun S
    Praxis (Bern 1994); 2013 May; 102(11):689-90. PubMed ID: 23692910
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Jolobe OM
    J Intern Med; 1997 Jul; 242(1):88-9. PubMed ID: 9260574
    [No Abstract]   [Full Text] [Related]  

  • 32. Persistent and severe hypoglycemia associated with trimethoprim-sulfamethoxazole in a frail diabetic man on polypharmacy: A case report and literature review
.
    Rossio R; Arcudi S; Peyvandi F; Piconi S
    Int J Clin Pharmacol Ther; 2018 Feb; 56(2):86-89. PubMed ID: 29191263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Author's response to troponin leak-Janus face of polypharmacy.
    Cannon RD; Wagner M; Jacoby JL
    Am J Emerg Med; 2014 Sep; 32(9):1129-30. PubMed ID: 25023175
    [No Abstract]   [Full Text] [Related]  

  • 34. Megaloblastic anaemia and pancytopenia secondary to prophylactic cotrimoxazole therapy.
    Tapp H; Savarirayan R
    J Paediatr Child Health; 1997 Apr; 33(2):166-7. PubMed ID: 9145363
    [No Abstract]   [Full Text] [Related]  

  • 35. Lack of definitive evidence for the use of renin-angiotensin system antagonists for heart failure with preserved ejection fraction.
    Khalid U; Deswal A
    Evid Based Med; 2013 Dec; 18(6):226-7. PubMed ID: 23585078
    [No Abstract]   [Full Text] [Related]  

  • 36. Sodium depletion in patients in clinical trials may account for the increased cardiovascular risk of dual blockade of the renin-angiotensin system.
    Laragh JH; Sealey JE
    BMJ; 2013 Mar; 346():f1685. PubMed ID: 23512453
    [No Abstract]   [Full Text] [Related]  

  • 37. Renin-angiotensin system inhibition is not associated with increased sudden cardiac death, cardiovascular mortality or all-cause mortality in patients with aortic stenosis.
    Bang CN; Greve AM; Køber L; Rossebø AB; Ray S; Boman K; Nienaber CA; Devereux RB; Wachtell K
    Int J Cardiol; 2014 Aug; 175(3):492-8. PubMed ID: 25012498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No need to change guidelines for diabetic retinopathy and renin-angiotensin system inhibitors.
    van Sloten TT; Stehouwer CD
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):231-2. PubMed ID: 25660573
    [No Abstract]   [Full Text] [Related]  

  • 39. [Renin-angiotensin system antagonists associated with reduced [corrected] mortality in diastolic heart failure].
    Edner M; Lund LH
    Lakartidningen; 2013 Feb 13-19; 110(7):331. PubMed ID: 23513377
    [No Abstract]   [Full Text] [Related]  

  • 40. Do the benefits of medications outweigh the burdens for hemodialysis patients?: comment on "Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients".
    Johansen KL
    Arch Intern Med; 2012 Apr; 172(7):593-4. PubMed ID: 22493469
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.